Cardiometabolic Health Congress

Healio brings you the highlights from the Cardiometabolic Health Congress. Refer back to this page often for the latest news from CMHC, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

Visceral adipose tissue holds clues to cardiometabolic risk

October 14, 2016
BOSTON — Intra-abdominal visceral fat plays a causal role in the development of almost all components of metabolic syndrome, irrespective of a…
Meeting News Coverage

Merits of warfarin, newer oral anticoagulants for patients with AF debated

October 13, 2016
BOSTON — At the Cardiometabolic Health Congress, one expert argued that warfarin remains the safe and effective gold standard for patients…
Meeting News Coverage

Bariatric surgery ‘powerful’ tool for understanding biology of obesity

October 11, 2016
BOSTON — A physiological regulation of energy balance drives most obesogenic behavior, and bariatric surgery is likely to best option to…
Meeting News Coverage

Consistency, early treatment key in obesity interventions

October 10, 2016
BOSTON — A variety of obesity interventions ranging from lifestyle modification to gastric bypass surgery are available for the approximately…
Meeting News CoveragePerspective

Insulin therapy in 2017: More options, but greater costs may limit use

October 10, 2016
BOSTON — Several new insulin therapies are anticipated for patients with diabetes in 2017; however, for many, cost may put the latest options…
Meeting News Coverage

Debate focuses on appropriateness of cangrelor, pretreatment with oral antiplatelets in patients undergoing PCI

October 8, 2016
BOSTON — At the Cardiometabolic Health Conference, one expert argued IV cangrelor should be used during PCI and has rendered the practice of…
Meeting News Coverage

Review of CV outcome trials for diabetes drugs shows neutral or positive results

October 7, 2016
BOSTON — At the Cardiometabolic Health Conference, Jay S. Skyler, MD, MACP, from the division of endocrinology, diabetes and metabolism and…
Meeting News Coverage

For SGLT2 inhibitors, big benefits come with some trade-offs

October 7, 2016
BOSTON — The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults…
Meeting News Coverage

SPRINT results reinforce connection between hypertension, HF

October 7, 2016
BOSTON — In the SPRINT trial, intensive BP therapy conferred reduced risk for CV events largely through reduction in HF, confirming research…
Meeting News Coverage

Lower BP confers better outcomes, even in patients with diabetes

October 7, 2016
BOSTON — The SPRINT trial and several meta-analyses suggest that more intensive reduction of systolic BP leads to better CV outcomes, but

Meeting Calendar

Cardiometabolic Health Congress

October 5, 2016 - October 8, 2016

Advertisement
Advertisement